DocDollars

Ardelyx, Inc.

MA · United States · Reporting entity ID 100001146890

Total reported 2019–2025
$11.0M
#462 of 2,960 reporting companies — 0% of all reported industry payments
$7.31M in general payments across 137,433 records, plus $3.74M in research funding across 1,300 records.

How it breaks down

General payments $7,309,452
Research funding $3,735,568

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ardelyx, Inc. reported $11.0M to US doctors and teaching hospitals from 2019 to 2025, ranking #462 of 2,960 reporting companies. 34% of that was research funding and 66% general payments such as consulting, speaking, food and travel. 137,433 general payment records and 1,300 research records were filed.

Common questions about Ardelyx, Inc.

How much has Ardelyx, Inc. paid US doctors?

Ardelyx, Inc. reported $11,045,020 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $7,309,452 in general payments, $3,735,568 in research funding.

How does Ardelyx, Inc. rank among drug and device companies?

It ranks #462 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ardelyx, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.